LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanded funding AltruBio secured a substantial Series B funding of up to 225 million dollars in May 2024, indicating strong investor confidence and potential for accelerated clinical development and partnering discussions.

Clinical momentum The company progressed into Phase 2 with ALTB-268 for ulcerative colitis as of December 2023, presenting an opportunity to engage on later-stage trials, companion diagnostics, and potential strategic collaborations.

Immunology focus AltruBio specializes in first-in-class immune-modulators for immunology and inflammation, suggesting demand for partnering in novel biologics, translational opportunities, and access to their early-stage assets.

Mid-stage scale With a modest headcount (11-50 employees) and mid-range revenue, AltruBio represents a target for CDMO, CRO, and manufacturing partners to support clinical development, scale-up, and commercialization planning.

Strategic partnerships Recent leadership and financial milestones, including Series A and CFO appointments, signal readiness for collaborations, licensing talks, and co-development opportunities with pharma and biotech players.

Similar companies to AltruBio Inc.

AltruBio Inc. Tech Stack

AltruBio Inc. uses 8 technology products and services including iCIMS, Open Graph, Microsoft 365, and more. Explore AltruBio Inc.'s tech stack below.

  • iCIMS
    Applicant Tracking Systems
  • Open Graph
    Content Management System
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Swiper
    Javascript Libraries
  • Piwik PRO Core
    Web Analytics
  • jQuery custom content scroller
    Web Tools And Plugins

AltruBio Inc.'s Email Address Formats

AltruBio Inc. uses at least 5 email formats:
AltruBio Inc. Email FormatsExamplePercentage
First.Last@abgenomics.comJohn.Doe@abgenomics.com
70%
FLast@abgenomics.comJDoe@abgenomics.com
30%
First.Last@altrubio.comJohn.Doe@altrubio.com
93%
FLast@altrubio.comJDoe@altrubio.com
5%
FirstMiddle.Last@altrubio.comJohnMichael.Doe@altrubio.com
2%

Frequently Asked Questions

What is AltruBio Inc.'s phone number?

Minus sign iconPlus sign icon You can contact AltruBio Inc.'s main corporate office by phone at
+1-650-988-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AltruBio Inc.'s official website and social media links?

Minus sign iconPlus sign iconAltruBio Inc.'s official website is altrubio.com and has social profiles on LinkedIn.

How much revenue does AltruBio Inc. generate?

Minus sign iconPlus sign icon As of August 2026, AltruBio Inc.'s annual revenue is estimated to be $1M - $10M.

What is AltruBio Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign iconAltruBio Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AltruBio Inc. have currently?

Minus sign iconPlus sign iconAs of August 2026, AltruBio Inc. has approximately 28 employees across 1 continents, including North America. Key team members include Vice President Of Clinical Operations: S. R., President, Chief Executive Officer, And Board Of Directors: J. C. and Vice President: S. L. Explore AltruBio Inc.'s employee directory with LeadIQ.

What industry does AltruBio Inc. belong to?

Minus sign iconPlus sign iconAltruBio Inc. operates in the Biotechnology Research industry.

What technology does AltruBio Inc. use?

Minus sign iconPlus sign iconAltruBio Inc.'s tech stack includes iCIMS, Open Graph, Microsoft 365, Font Awesome, Google Fonts API, Swiper, Piwik PRO Core and jQuery custom content scroller.

What is AltruBio Inc.'s email format?

Minus sign iconPlus sign iconAltruBio Inc.'s email format typically follows the pattern of First.Last@abgenomics.com. Find more AltruBio Inc. email formats with LeadIQ.

How much funding has AltruBio Inc. raised to date?

Minus sign iconPlus sign icon As of August 2026, AltruBio Inc. has raised $328M in funding. The last funding round occurred on May 21, 2024.

When was AltruBio Inc. founded?

Minus sign iconPlus sign iconAltruBio Inc. was founded in 2020.
AltruBio Inc. logo

AltruBio Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

AltruBio Inc. is a biotechnology research company focused on developing first-in-class immune-modulators for immunology and inflammation. Its work aims to translate advances in immune biology into biologic treatments addressing diseases with high unmet medical needs. The company assembles a global team with expertise in immunology and drug development to advance these therapies toward patients. It is based in San Francisco, California, and operates within the biotechnology research sector.

Its focus is on addressing immune-mediated inflammatory conditions where current therapies are insufficient. A notable recent development is the enrollment of the first patient in a Phase 2 study of ALTB-268 for ulcerative colitis.

Section iconCompany Overview

Phone number
+1-650-988-****
Website
altrubio.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $328M

    AltruBio Inc. has raised a total of $328M of funding over 5 rounds. Their latest funding round was raised on May 21, 2024 as a Series B.

  • $1M - $10M

    AltruBio Inc.'s revenue is estimated to be in the range of $1M - $10M

Company Leadership

  • Vice President Of Clinical Operations at AltruBio Inc.
    S. R.
    Vice President Of Clinical Operations
    Mobile Phone
  • President, Chief Executive Officer, And Board Of Directors at AltruBio Inc.
    J. C.
    President, Chief Executive Officer, And Board Of Directors
    Mobile Phone
  • Vice President at AltruBio Inc.
    S. L.
    Vice President
    Mobile Phone
  • Associate Director Of Project Managment at AltruBio Inc.
    Z. H. C.
    Associate Director Of Project Managment
    Mobile Phone
  • Director Drug Product Development at AltruBio Inc.
    S. G.
    Director Drug Product Development
    Mobile Phone

Employee Directory

  • Director, Clinical Project Management at AltruBio Inc.
    I. C.
    Director, Clinical Project Management
    Mobile Phone
  • Director, Cmc Project Management at AltruBio Inc.
    C. L.
    Director, Cmc Project Management
    Mobile Phone
  • Director Of Protein Science at AltruBio Inc.
    Y. H.
    Director Of Protein Science
    Mobile Phone
  • Associate Director at AltruBio Inc.
    K. W.
    Associate Director
    Mobile Phone
  • Principal Scientist at AltruBio Inc.
    E. F. C.
    Principal Scientist
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.